Long-term, successful maintenance of bilateral cytomegalovirus retinitis using exclusively local therapy

Archives of Ophthalmology

Volumn 114, Issue 7, 1996, Pages 881-882

  Duker, Jay S ^a,b   Ashton, Paul ^a   Davis, Janet L ^a   Keller, Robert ^a   Chuang, Elaine ^a  

^a Tufts University School of Medicine ^*

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR;

ARTICLE; DISEASE CONTROL; DOSE RESPONSE; FOLLOW UP; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETINITIS; VISUAL ACUITY;

EID: 0029999906     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100140095021     Document Type: Article

References (3)

1. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. Arch Ophthalmol 1994;112:1531-1539.
2. Anand R, Nightingale SD, Fish RH, Smith TJ, Ashton P. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol. 1993;111:223-227.
3. Holland GN, Sison RF, Jatulis DE, et al. Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. Ophthalmology. 1990; 97:204-211.